Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Seoul National University College of Medicine, 101, Daehak-ro, Jongno-gu, Seoul, 03080, South Korea.
Department of Mathematics and Statistics, Sejong University College of Natural Sciences, Seoul, South Korea.
J Gastrointest Surg. 2022 Aug;26(8):1705-1712. doi: 10.1007/s11605-022-05368-z. Epub 2022 May 31.
Sequential extended cholecystectomy (SEC) is currently recommended for T2 and higher gallbladder cancer (GBC) diagnosed after simple cholecystectomy (SC), but the value and timing of re-resection has not been fully studied. We evaluated the long-term oncologic outcomes of T2 GBC according to the type of surgery performed and investigated the optimal timing for SEC.
Patients diagnosed with T2 GBC who underwent SC, extended cholecystectomy (EC), or SEC between 2002 and 2017 were retrospectively reviewed. Those who underwent other surgical procedures or those with incomplete medical records were excluded. Overall survival (OS) and disease-free survival (DFS) according to the types of surgeries and prognostic factors for OS and DFS were analyzed. Survival analysis was done between groups that were divided according to the optimal cutoff time interval between SC and SEC based on DFS data.
Of the 226 T2 GBC patients, 53, 173, and 44 underwent SC, EC, and SEC, respectively. The 5-year OS rate was 50.1%, 73.2%, and 78.7%, and the DFS rate was 46.8%, 66.3%, and 65.2% in the SC, EC, and SEC groups, respectively. EC (p = 0.001 and p = 0.001) and SEC (p = 0.007 and p = 0.065) groups had better 5-year OS and DFS rates than the SC group. Preoperative CA 19-9 level > 37 U/mL (HR 1.56; 95% CI 1.87-2.79; p < 0.001) and N1 stage (HR 2.88; 95% CI 1.76-4.71; p < 0.001) were associated with poorer prognosis. The optimal cutoff interval between SC and SEC was 28 days. Patients who underwent SEC ≤ 28 days after the initial cholecystectomy had better 5-year DFS rates than patients who underwent SEC after > 28 days (75.0% vs. 52.8%, p = 0.023).
SEC is recommended for T2 GBC diagnosed after SC, because SEC provides better survival outcomes than SC alone. A time interval of less than 28 days to SEC is associated with an improved DFS.
对于在单纯胆囊切除术(SC)后诊断出的 T2 及更高分级的胆囊癌(GBC),目前推荐进行序贯扩大胆囊切除术(SEC),但再次切除的价值和时机尚未得到充分研究。我们根据所行手术类型评估了 T2 GBC 的长期肿瘤学结局,并探讨了 SEC 的最佳时机。
回顾性分析了 2002 年至 2017 年间接受 SC、扩大胆囊切除术(EC)或 SEC 的 T2 GBC 患者。排除了接受其他手术或病历不完整的患者。根据手术类型和总生存(OS)和无病生存(DFS)的预后因素分析了 OS 和 DFS。根据 DFS 数据,基于最佳截止时间间隔将患者分为两组,并对生存分析进行了比较。
在 226 例 T2 GBC 患者中,分别有 53、173 和 44 例患者接受了 SC、EC 和 SEC。SC、EC 和 SEC 组的 5 年 OS 率分别为 50.1%、73.2%和 78.7%,DFS 率分别为 46.8%、66.3%和 65.2%。EC(p=0.001 和 p=0.001)和 SEC(p=0.007 和 p=0.065)组的 5 年 OS 和 DFS 率均优于 SC 组。术前 CA19-9 水平>37 U/mL(HR 1.56;95%CI 1.87-2.79;p<0.001)和 N1 期(HR 2.88;95%CI 1.76-4.71;p<0.001)与预后不良相关。SC 和 SEC 之间的最佳截止间隔为 28 天。与 SEC 后>28 天的患者相比,SC 后≤28 天行 SEC 的患者 5 年 DFS 率更高(75.0% vs. 52.8%,p=0.023)。
对于在 SC 后诊断出的 T2 GBC,建议行 SEC,因为 SEC 提供的生存结果优于单独 SC。SEC 时间间隔<28 天与 DFS 改善相关。